Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 453-455

  Odland, Brant A ^a   Erwin, Meredith E ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXOMYCIN; APRAMYCIN; TIAMULIN; TILMICOSIN; TYLOSIN; UNCLASSIFIED DRUG; VETERINARY DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VETERINARY MEDICINE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MACROLIDES; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL;

EID: 0033981925     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Donnelly, J. P., A. Voss, W. Witte, and B. E. Murray. 1996. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? J. Antimicrob. Chemother. 37:388-390.
2. Ira, D., A. Fraise, and R. Wise. 1997. Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet 349:997-998.
3. Jones, R. N., Y. Chen, and S. A. Marshall. 1998. Comparative in vitro activity of alexomycin (U-82127) tested against Escherichia coli, Salmonella spp., and enterococci of animal and human origin. Clin. Microbiol. Infect. 4:601-603.
4. Marshall, S. A., R. N. Jones, A. Wanger, J. A. Washington, G. V. Doern, A. L. Leber, and T. H. Haugen. 1996. Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. J. Clin. Microbiol. 34:2027-2029
5. McDonald, M. C., and E. L. Biberstein. 1974. Determination of bacterial susceptibility to tylosin by single-disk agar diffusion tests. Am. J. Vet. Res. 35:1563.
6. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial disk and dilution susceptibility tests tor bacteria isolated from animals. Proposed standard M31-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
7. National Committee for Clinical Laboratory Standards. 1994. Development of in vitro susceptibility criteria and quality control parameters for veterinary antimicrobial agents. Approved guideline M37-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. Piddock, L. J. 1996. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy. J. Antimicrob. Chemother. 38:1-3.
9. Shryock, T. R., D. W. White, C. S. Werner, and J. M. Staples. 1995. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin. J. Clin. Microbiol. 33:331-335.
10. Stegemann, M., P. C. T. Hannan, G. D. Windsor, A. deJong, and N. Schmeer. 1997. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob. Agents Chemother. 41:2037-2040.
11. Taylor, D. J. 1980. Tiamulin in the treatment and prophylaxis of experimental swine dysentery. Vet. Rec. 106:114.
12. Walton, J. R. 1978. Apramycin, a new aminocyclitol antibiotic. J. Antimicrob. Chemother. 4:309-313.
13. Zerva, L., S.A. Marshall, and R. N. Jones. 1996. Premafloxacin: a projected veterinary use fluoroquinolone with significant activity against multi-resistant gram-positive human pathogens. J, Antimicrob. Chemother. 38:742-744.